Literature DB >> 7814823

Differential acute psychomotor and cognitive effects of diazepam on long-term benzodiazepine users.

C Gorenstein1, M A Bernik, S Pompéia.   

Abstract

The aim of this study is to determine whether long-term use (5-20 years) of therapeutic doses of diazepam (5-20 mg/day) in anxious patients (n = 28) is associated with tolerance to its psychomotor and cognitive effects. Patients were tested at baseline, before and after a 10 mg oral dose of diazepam during chronic use, and at 3 weeks and 10 months after benzodiazepine (BZ) discontinuation. The effects of a single i.v. dose of flumazenil (1 mg administered 5 days before baseline) on reversing tolerance were also assessed. No acute effect of diazepam was observed on the psychomotor performance of patients both under BZ treatment and after short- and long-term discontinuation, suggesting persistence of tolerance. In contrast, acute effects of diazepam were observed in memory measures at all times. Given subjects' very prolonged BZ use, it is possible to predict that tolerance to the memory effects never fully develops. Flumazenil administration did not reverse tolerance. This suggests that neuroadaptative mechanisms, other than benzodiazepine receptor set-point shift, occur after long-term use.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7814823     DOI: 10.1097/00004850-199409000-00002

Source DB:  PubMed          Journal:  Int Clin Psychopharmacol        ISSN: 0268-1315            Impact factor:   1.659


  8 in total

1.  Short-term and long-term effects of diazepam on the memory for discrimination and generalization of scopolamine.

Authors:  C Casasola-Castro; L Weissmann-Sánchez; E Calixto-González; A Aguayo-Del Castillo; D N Velázquez-Martínez
Journal:  Psychopharmacology (Berl)       Date:  2017-07-22       Impact factor: 4.530

Review 2.  Behavioural toxicity of medicinal drugs. Practical consequences, incidence, management and avoidance.

Authors:  J G Ramaekers
Journal:  Drug Saf       Date:  1998-03       Impact factor: 5.606

Review 3.  Benzodiazepine harm: how can it be reduced?

Authors:  Malcolm Lader
Journal:  Br J Clin Pharmacol       Date:  2014-02       Impact factor: 4.335

4.  Cognitive effects of long-term benzodiazepine use: a meta-analysis.

Authors:  Melinda J Barker; Kenneth M Greenwood; Martin Jackson; Simon F Crowe
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

5.  Psychomotor and anxiolytic effects of mexazolam in patients with generalised anxiety disorder.

Authors:  Luís Ferreira; Maria-Luísa Figueira; Alberto Bessa-Peixoto; António Marieiro; Rodolfo Albuquerque; Cristina Paz; Ana Cerqueira; Pedro Damião; Ana Dolgner; Jasper Dingemanse
Journal:  Clin Drug Investig       Date:  2003       Impact factor: 2.859

6.  Adverse performance effects of acute lorazepam administration in elderly long-term users: pharmacokinetic and clinical predictors.

Authors:  Nunzio Pomara; Sang Han Lee; Davide Bruno; Timothy Silber; David J Greenblatt; Eva Petkova; John J Sidtis
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2014-09-06       Impact factor: 5.067

Review 7.  Withdrawing benzodiazepines in primary care.

Authors:  Malcolm Lader; Andre Tylee; John Donoghue
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

8.  High-dose benzodiazepine dependence: a qualitative study of patients' perception on cessation and withdrawal.

Authors:  Michael Liebrenz; Marie-Therese Gehring; Anna Buadze; Carlo Caflisch
Journal:  BMC Psychiatry       Date:  2015-05-13       Impact factor: 3.630

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.